Priority Date: 27.07.12 (EP 20120305926)

DERIVATIVES OF AZAINDAZOLE OR DIAZAINDAZOLE TYPE FOR TREATING A CANCER OVEREXPRESSING TRK

  • Application ID: EP13741791
  • Status: PATENT GRANTED

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 201 - 500 employees
Company dna regimbeau
operating since 1931
Headquarter in Paris and 8 offices
active in Legal Services and IP Consulting

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Cabinet Regimbeau is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 27.07.2012 - Priority Date (EP 20120305926)
  • 30.01.2014 - Publication A1 (WO2014016434)
  • 03.06.2015 - Publication A1 (EP2877176)
  • 26.04.2017 - Publication B1 (EP2877176)